HPV Vaccine (Gardasil) - National Monitoring Overview
19 July 2011
This update provides an overview of the reports of suspected adverse reactions received by the IMB in association with Gardasil. It includes all reports received up to June 2011 and incorporates the first year of the HSE human papillomavirus (HPV) Schools Immunisation Programme.
Overview of National Monitoring Experience with Gardasil
For further information about Gardasil, including the product information, visit the HPV School Immunisation section of our website.